Results for the substance ziconotide

Ziconotide is a potent analgesic used for the treatment of severe chronic pain, particularly in patients who do not respond to other therapies or cannot tolerate opioids. It is a synthetic analog of a natural toxin (conotoxin) derived from the venom of the marine cone snail Conus magus. Ziconotide works by blocking N-type calcium channels in the spinal cord, thereby reducing the transmission of pain signals to the brain.

The mechanism of action of ziconotide involves inhibiting the release of neurotransmitters involved in pain perception. By blocking N-type calcium channels, it reduces the activity of neurons responsible for transmitting pain, providing significant relief from chronic pain. Ziconotide is administered via an intrathecal pump, which delivers the medication directly into the cerebrospinal fluid, ensuring localized and effective action.

While effective, ziconotide can cause side effects. The most common include nausea, dizziness, confusion, drowsiness, headache, and muscle weakness. In rare cases, more serious reactions such as psychiatric disturbances (depression, hallucinations) or infections related to the intrathecal delivery device may occur. Close monitoring of patients during treatment is essential to detect and manage potential complications promptly.

Ziconotide is contraindicated in patients with a history of severe psychiatric disorders or active central nervous system infections. The treatment must be administered under the strict supervision of a pain specialist or neurologist, and the dosage should be gradually adjusted to minimize the risk of side effects.